CDEK
← All organizations

New River Pharmaceuticals

For profitContributed to NME

Also known as: NEW RIVER

Phase 1Phase 2Phase 3Phase 4

Highest phase reached

Phase 3

First clinical trial

Sep 1, 2004

First marketed drug

Jan 1, 1996

First NDA

Feb 23, 2007

Last known activity

Jul 1, 2006

Acquired by Shire → Takeda on Feb 21, 2007

Timeline

1960s

  1. Aug 23, 1965

    amitriptyline— Marketing Organization

  2. Aug 23, 1965

    amitriptyline— NDA Secondary Org

1990s

  1. Jan 1, 1996

    New River Pharmaceuticals— Founded

2000s

  1. Feb 21, 2007

    Shire— Acquired By

  2. Feb 23, 2007

    lisdexamfetamine— NDA Organization

2010s

  1. Jan 1, 2011

    Pinnacle Pharmaceuticals— Acquired

  2. Dec 3, 2018

    Takeda— Now

Drugs by trial phase (3 distinct, 7 trials)

Phase 3 (1 own, 0 via acquisition)

Phase 2 (1 own, 1 via acquisition)

Indications

Approved for

Studied for

Marketed drugs (5)

Subsidiaries (1 direct, 1 total across the full acquisition tree)

Recent trials (7)

Details

Founded
Radford, VA, US Jan 1, 1996
First NDA
Feb 23, 2007
Last known activity
Jul 1, 2006

Notes

Acquired by shire